Nu Skin Enterprises Inc (NUS) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Nu Skin Enterprises Inc stock (NUS) is currently trading at $7.29. Nu Skin Enterprises Inc PE ratio is 4.47. Nu Skin Enterprises Inc PS ratio (Price-to-Sales) is 0.23. Analyst consensus price target for NUS is $7.50. WallStSmart rates NUS as Moderate Buy.
- NUS PE ratio analysis and historical PE chart
- NUS PS ratio (Price-to-Sales) history and trend
- NUS intrinsic value — DCF, Graham Number, EPV models
- NUS stock price prediction 2025 2026 2027 2028 2029 2030
- NUS fair value vs current price
- NUS insider transactions and insider buying
- Is NUS undervalued or overvalued?
- Nu Skin Enterprises Inc financial analysis — revenue, earnings, cash flow
- NUS Piotroski F-Score and Altman Z-Score
- NUS analyst price target and Smart Rating
Nu Skin Enterprises Inc
📊 No data available
Try selecting a different time range
NUS Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · Nu Skin Enterprises Inc (NUS)
NUS trades at a significant discount to its Graham intrinsic value of $102.49, offering a 90% margin of safety — a level value investors typically seek before buying.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.
Smart Analysis
Nu Skin Enterprises Inc (NUS) · 10 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in peg ratio, price/sales, price/book. Concerns around operating margin and revenue growth. Overall metrics suggest strong investment potential with favorable risk/reward.
Nu Skin Enterprises Inc (NUS) Key Strengths (5)
Growing significantly faster than its price suggests
Paying less than $1 for every $1 of annual revenue
Trading below book value, meaning the market prices it less than net assets
Earnings per share surging 103.60% year-over-year
78.25% of shares held by major funds and institutions
Supporting Valuation Data
Nu Skin Enterprises Inc (NUS) Areas to Watch (5)
Revenue declining -15.30%, a shrinking business
Very thin margins with limited operational efficiency
Thin profit margins with limited profitability
Small-cap company with higher risk but more growth potential
Moderate profitability with room for improvement
Supporting Valuation Data
Nu Skin Enterprises Inc (NUS) Detailed Analysis Report
Overall Assessment
This company scores 67/100 in our Smart Analysis, earning a B- grade. Out of 10 metrics analyzed, 5 register as strengths (avg 10.0/10) while 5 fall into concern territory (avg 3.2/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on PEG Ratio, Price/Sales, Price/Book. Valuation metrics including PEG Ratio (0.78), Price/Sales (0.23), Price/Book (0.42) suggest the stock is attractively priced. Growth metrics are encouraging with EPS Growth at 103.60%.
The Bear Case
The primary concerns are Revenue Growth, Operating Margin, Profit Margin. Growth concerns include Revenue Growth at -15.30%, which may limit upside. Profitability pressure is visible in Return on Equity at 14.50%, Operating Margin at 5.94%, Profit Margin at 7.02%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Revenue Growth improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 14.50% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at -15.30% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a moderate-to-high risk investment. Strengths and concerns are roughly balanced. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Mixed fundamentals with both positives (PEG Ratio, Price/Sales) and negatives (Revenue Growth, Operating Margin). A cautious approach is warranted. Monitor for improvement in weak areas before increasing conviction.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
NUS Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
NUS's Price-to-Sales ratio of 0.23x trades at a deep discount to its historical average of 1.03x (1th percentile). The current valuation is 92% below its historical high of 3.08x set in Dec 2013, and 1% above its historical low of 0.23x in Mar 2026. Over the past 12 months, the PS ratio has compressed from ~0.3x as trailing revenue scaled faster than the stock price.
WallStSmart Analysis Synopsis
Data-driven financial summary for Nu Skin Enterprises Inc (NUS) · CONSUMER DEFENSIVE › HOUSEHOLD & PERSONAL PRODUCTS
The Big Picture
Nu Skin Enterprises Inc operates as a stable business with moderate growth and solid fundamentals. Revenue reached 1.6B with 15% decline year-over-year. Profit margins are thin at 7.0%, typical for companies in this phase that are reinvesting heavily in growth.
Key Findings
Generating 6M in free cash flow and 17M in operating cash flow. Earnings are translating into actual cash generation.
Revenue contracted 15% YoY. Worth determining whether this is cyclical or structural.
What to Watch Next
Margin expansion: can Nu Skin Enterprises Inc push profit margins above 15% as the business scales?
Sector dynamics: monitor HOUSEHOLD & PERSONAL PRODUCTS industry trends, competitive moves, and regulatory changes that could impact Nu Skin Enterprises Inc.
Bottom Line
Nu Skin Enterprises Inc offers stability with moderate growth and solid fundamentals. The valuation may present an opportunity for patient investors, though limited growth means returns will likely come from dividends and modest capital appreciation rather than explosive gains.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions(26 last 3 months)
| Insider | Type | Shares |
|---|---|---|
WOODBURY, EDWINA D Director | Buy | +14 |
Data sourced from SEC Form 4 filings
Last updated: 2:34:43 PM
About Nu Skin Enterprises Inc(NUS)
NYSE
CONSUMER DEFENSIVE
HOUSEHOLD & PERSONAL PRODUCTS
USA
Nu Skin Enterprises, Inc. develops and distributes wellness and personal care products globally. The company is headquartered in Provo, Utah.